Literature for ASP8497 (S09.003 inhibitor)

(Topics flags: I Inhibitor. To select only the references relevant to a single topic, click the link above. See explanation.)

2009
1. Matsuyama-Yokono,A., Tahara,A., Nakano,R., Someya,Y., Hayakawa,M. and Shibasaki,M.
   Chronic inhibition of dipeptidyl peptidase-IV with ASP8497 improved the HbA(1c) level, glucose intolerance, and lipid parameter level in streptozotocin-nicotinamide-induced diabetic mice
   Naunyn Schmiedebergs Arch Pharmacol379, 191-199. PubMed  Europe PubMed DOI  I
2008
2. Matsuyama-Yokono,A., Tahara,A., Nakano,R., Someya,Y., Nagase,I., Hayakawa,M. and Shibasaki,M.
   ASP8497 is a novel selective and competitive dipeptidyl peptidase-IV inhibitor with antihyperglycemic activity
   Biochem Pharmacol76, 98-107. PubMed  Europe PubMed DOI  I
3. Someya,Y., Tahara,A., Nakano,R., Matsuyama-Yokono,A., Nagase,I., Fukunaga,Y., Takasu,T., Hayakawa,M. and Shibasaki,M.
   Pharmacological profile of ASP8497, a novel, selective, and competitive dipeptidyl peptidase-IV inhibitor, in vitro and in vivo
   Naunyn Schmiedebergs Arch Pharmacol377, 209-217. PubMed  Europe PubMed DOI  I